Schonfeld Strategic Advisors LLC Silence Therapeutics PLC Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 149,996 shares of SLN stock, worth $838,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,996
Previous 123,200
21.75%
Holding current value
$838,477
Previous $847,000
50.18%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding SLN
# of Institutions
62Shares Held
21.8MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$17 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$16.3 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.4 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11.2 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.3 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $201M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...